What does Neurogenesis, Inc. do?

Neurogenesis, Inc. (NEUN) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NEUN's market cap?

Neurogenesis, Inc. (NEUN) has a market capitalization of approximately $8,226, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does NEUN pay a dividend?

No — Neurogenesis, Inc. (NEUN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

NEUN

Neurogenesis, Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$8.23K·Market closed·Aug 26 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−98.46%CAGR −56.65%

Select date range

FromTo

Jun 8, 1998Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

NEUN does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 6

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how NEUN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NEUN and 80,000+ other tickers.

About Neurogenesis, Inc.

Neurogenesis, Inc. manufactures and sells nutritional supplements primarily in the United States. The company offers NeuBecalm’d, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress and enhance focus; and NeuRecover, a nutritional support for the natural replenishment of neurotransmitters depleted by the long-term use of alcohol. It also provides NeuReplenish, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of chemical…

CEO: Tal Gilat
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 307
Website: www.neurogenesis.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NEUN

What does Neurogenesis, Inc. do?: Neurogenesis, Inc. (NEUN) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NEUN's market cap?: Neurogenesis, Inc. (NEUN) has a market capitalization of approximately $8,226, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does NEUN pay a dividend?: No — Neurogenesis, Inc. (NEUN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.